Modulation of neutrophil migration and superoxide anion release by metoprolol

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 6, 2000, Pages 915-924

  Dunzendorfer, S ^a   Wiedermann, C J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Migration; Neutrophils; Protein kinase C; Respiratory burst; Blockers

Indexed keywords

ATENOLOL; METOPROLOL; METOPROLOL TARTRATE; ORCIPRENALINE; PROPRANOLOL; SUPEROXIDE;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 0033836798     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1148     Document Type: Article

References (39)

1. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in dilated cardiomyopathy (MDC) trial study group
2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)
3. The effects of carvedilol on morbidity and mortality in patients with chronic heart failure
4. Carvedilol: A new β-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils
5. Propranolol: A phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C
6. Oxygen radical-mediated injury of myocytes-protection by propranolol
7. Free radical scavenging and inhibition of lipid peroxidation by β-blockers and by agents that interfere with calcium metabolism
8. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
9. Quality of life on treatment with metoprolol in dilated cardiomyopathy: Results from the MDC trial
10. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: A double-blind, randomized, placebo-controlled trial
11. Improvement in cardiac myocyte function by biological effects of medical therapy: A new concept in the treatment of heart failure
12. Long-term treatment with metoprolol does not increase cAMP levels in left ventricular myocardium of dogs with heart failure
13. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure
14. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha
15. Pre-clamp cardioprotection by protein kinase C (PKC) inhibitor improves left ventricular function following canine normothermic arrest
16. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase
17. Role of intracellular Ca2+ in activation of protein kinase C during ischemic preconditioning
18. Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin
19. Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro
20. Visual methods for measuring leukocyte locomotion
21. An automated micro-fluorometric assay for monitoring oxidative burst activity of phagocytes
22. In vitro assays of protein kinase C activity
23. Activation of carbonic anhydrase by beta-adrenergic agonists and inhibition by beta-adrenergic blockers
24. The effect of putative protein kinase C inhibitors, K252a and staurosporine, on the human neutrophil respiratory burst activated by both receptor stimulation and post-receptor mechanism
25. Role of granulocytes in endothelial injury in coronary heart disease in humans
26. Role of protein kinase C in cell surface signal transduction and tumor promotion
27. Superoxide release by neutrophils: Synergistic effects of a phorbol ester and a calcium ionophore
28. Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils
29. Signal transduction pathways in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor
30. Beta-adrenergic blockade: Augmentation of neutrophil-mediated inflammation
31. The anti-proliferative effects of staurosporine are not exclusively mediated by inhibition of protein kinase C
32. Phorbol myristate acetate induction of chemotactic migration of human polymorphonuclear neutrophils
33. Effect of the protein kinase C inhibitor GF 109 203X on elastase release and respiratory burst of human neutrophils
34. Protein kinase C activity is not involved in N-formylmethionin-leucyl-phenylalanine-induced phospholipase D activation in human neutrophils, but is essential for concomitant NADPH oxidase activation: Studies with a staurosporine analogue with improved selectivity for protein kinase C
35. Neutrophil function in ischemic heart disease
36. Effect of hyperoxia on adhesion molecule expression in human endothelial cells and neutrophils
37. Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1
38. MAC-1 mediates adherence of human monocytes to endothelium via a protein kinase C dependent mechanism
39. Attenuation of myocardial ischaemic injury 24h after di-acylglycerol treatment in vivo